Literature DB >> 6191579

Cell site and time course of DNA synthesis in pancreas after caerulein and secretin.

T E Solomon, M Vanier, J Morisset.   

Abstract

Pancreatic weight, [3H]-thymidine incorporation into DNA, labeling indices, and total DNA and RNA content were measured in rats treated with vehicle or 1 microgram/kg caerulein, 100 micrograms/kg secretin, or a combination of these peptides injected every 8 h for 1-5 days. Incorporation of [3H]thymidine into DNA increased 12-fold after 2 days of treatment with the combination of peptides. DNA content increased after 3 days and reached a level 1.8 times control after 5 days. Autoradiography showed that two cell types, acinar and an unidentified type, were the sites of increased DNA synthesis. Different patterns of labeling were seen in the two populations: acinar cell labeling indices were increased at 1 and 2 days (20-fold) and then fell; nonacinar cells showed an increase only after 2 days and maintained this increase after 5 days. Potentiation (greater than additive effects) was found when caerulein and secretin were injected together for all measurements except RNA content. These data indicate that DNA synthesis in two cell populations is affected by secretin and caerulein and support the occurrence of potentiation between secretin and caerulein for trophic effects on the exocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191579     DOI: 10.1152/ajpgi.1983.245.1.G99

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Dissimilar trophic effects of cerulein and xenopsin on the rat pancreas.

Authors:  G E Feurle; G Ohnheiser; C Löser
Journal:  Int J Pancreatol       Date:  1990-03

Review 2.  Cholecystokinin and pancreatic cancer: the chicken or the egg?

Authors:  Jill P Smith; Travis E Solomon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

Review 3.  The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

Authors:  Venu Gopal Jonnalagadda; Allam Venkata Sita Ram Raju; Srinivas Pittala; Afsar Shaik; Nilakash Annaji Selkar
Journal:  Adv Pharm Bull       Date:  2014-02-07

4.  Effects of calcium mediated secretagogues on the growth of pancreatic acinar cells in vitro.

Authors:  C D Logsdon
Journal:  Gut       Date:  1987       Impact factor: 23.059

5.  Small bowel bypass prevents the trophic action of cholecystokinin on the rat pancreas.

Authors:  C Stock-Damgé; M Aprahamian; E Lhoste; J Marescaux; E Loza
Journal:  Int J Pancreatol       Date:  1987-08

6.  Cholecystokinin activation of 70-kDa S6 kinase in exocrine pancreas.

Authors:  K Inushima; Y Okabayashi; K Sakaguchi; Y Matsumura; S Kimura; Y Inoue; M Kasuga
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 7.  Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

Authors:  L C Rovati
Journal:  Int J Pancreatol       Date:  1991-04

8.  Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.

Authors:  Gail L Matters; Timothy K Cooper; Christopher O McGovern; Evan L Gilius; Jiangang Liao; Brian M Barth; Mark Kester; Jill P Smith
Journal:  Dig Dis Sci       Date:  2014-05-11       Impact factor: 3.199

9.  Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.

Authors:  B Ohlsson; J Axelson; B Sternby; J F Rehfeld; I Ihse
Journal:  Int J Pancreatol       Date:  1995-08

10.  Effect of secretin on growth of stomach, small intestine, and pancreas of developing rats.

Authors:  P F Pollack; J G Wood; T Solomon
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.